ELITE PHARMACEUTICALS INC /NV/ (ELTP)
SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 28, 2026
as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗
In its 10-Q for the period ended Jun 30, 2026, ELITE PHARMACEUTICALS INC /NV/ reported revenue of $32.4M, net income of $5.9M, and total assets of $139.7M. Every figure below is taken directly from ELITE PHARMACEUTICALS INC /NV/'s SEC filings: each links to the source document on EDGAR.
Revenue trend
Revenue · FY2017–FY2026 · as reported
- FY2017 revenue
- $9.6M
- FY2026 revenue
- $148.9M
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2026 | $148.9M | $44.9M |
| FY2025 | $84.0M | -$4.3M |
| FY2024 | $56.6M | $20.1M |
| FY2023 | $34.2M | $3.6M |
| FY2022 | $32.3M | $8.9M |
| FY2021 | $25.4M | $5.1M |
| FY2020 | $18.0M | -$2.2M |
| FY2019 | $7.6M | -$9.3M |
| FY2018 | $7.5M | -$3.7M |
| FY2017 | $9.6M | $3.8M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | Aug 13, 2026 | on EDGAR ↗ |
| 10-Q | Aug 13, 2026 | on EDGAR ↗ |
| 8-K | Aug 10, 2026 | on EDGAR ↗ |
| 8-K | Aug 4, 2026 | on EDGAR ↗ |
| 10-K | Jun 29, 2026 | on EDGAR ↗ |
| 8-K | Jun 29, 2026 | on EDGAR ↗ |
| 8-K | Jun 23, 2026 | on EDGAR ↗ |
| 8-K | Jun 15, 2026 | on EDGAR ↗ |
| 8-K | Jun 1, 2026 | on EDGAR ↗ |
| 8-K | Apr 2, 2026 | on EDGAR ↗ |
Balance Sheet
as of Jun 30, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Jun 30, 2026
Per Share & Cash Flow
10-Q (quarterly) · period ended Jun 30, 2026
| EPS (diluted) | $0.01 | Earnings | source ↗ |
| EPS (basic) | $0.01 | Earnings | source ↗ |
| Shares Outstanding | 1.08B | Entity | source ↗ |
| Cash from Operations | $10.1M | Net | source ↗ |
| Cash from Financing | -$114,594 | Net | source ↗ |
| Cash from Investing | -$808,964 | Net | source ↗ |
Insider activity
Form 4 open-market activity, last 180 days
- Buys
- 2
- Sells
- 0
- Net shares
- +130.0K
Restatement history
Point-in-time6 of 473 annual fact-keys were materially restated between filings: what ELITE PHARMACEUTICALS INC /NV/ first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.
See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.
Deeper fundamentals
A free API key reaches ELTP’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/ELTP
MCP tool:
get_sec_fundamentals ticker=ELTP - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/ELTP/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=ELTP as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/ELTP/history
MCP tool:
get_fundamentals_history ticker=ELTP - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/ELTP
MCP tool:
get_financial_health ticker=ELTP
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.